Mexico - Delayed Quote MXN

Vertex Pharmaceuticals Incorporated (VRTX.MX)

8,214.30

-324.26

(-3.80%)

At close: May 14 at 1:58:56 PM CST

Are Investors Making a Big Mistake Dumping Shares of CRISPR Therapeutics?

CRISPR Therapeutics has an approved gene-therapy treatment still in its early growth stages. One of them is CRISPR Therapeutics (NASDAQ: CRSP). Its financials haven't been looking all that impressive and as a result, growth investors have been dumping the stock.

Motley Fool 12 hours ago

CRSP

VRTX
Q1 Therapeutics Earnings: United Therapeutics (NASDAQ:UTHR) Impresses

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, including United Therapeutics (NASDAQ:UTHR) and its peers.

StockStory 21 hours ago

UTHR

ABBV

SRPT
2 Biotech Stocks That Are Screaming Buys in May

Two biotech stocks make perfect candidates for this sort of strategy right now. Let's take a close look at these two biotech stocks that are screaming buys in May. The launch and revenue growth processes take longer for such a product than for standard medicines because gene editing involves several steps.

Motley Fool yesterday

CRSP

VRTX
This Stock Just Dropped by 12% in 1 Day. History Says This Will Happen Next

Vertex Pharmaceuticals' shares dropped due to poor first-quarter results. Vertex's business and prospects remain attractive. Vertex Pharmaceuticals (NASDAQ: VRTX), a leading drugmaker, is performing exceedingly well for the year -- or at least it was, until it released its first-quarter update.

Motley Fool yesterday

VRTX
Prediction: These 2 Stocks Will Outperform the Market in the Next Five Years

Vertex Pharmaceuticals is diversifying its already strong lineup of medicines. Axsome Therapeutics has multiple clinical and regulatory catalysts on the way. Two excellent candidates are Vertex Pharmaceuticals (NASDAQ: VRTX) and Axsome Therapeutics (NASDAQ: AXSM).

Motley Fool 2 days ago

VRTX

AXSM
Can Buying CRISPR Therapeutics and Holding It Forever Make You a Millionaire?

The company has shown its revolutionary technology can deliver life-changing therapies. Now, it's about whether CRISPR Therapeutics can replicate the success across its promising pipeline.

Motley Fool 2 days ago

CRSP

VRTX
Is Vertex Pharmaceuticals (VRTX) Among the Best Stocks to Buy According to Jim Simons’ Renaissance Technologies?

We recently published a list of 15 Best Stocks to Buy According to Jim Simons’ Renaissance Technologies In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against other best stocks to buy according to Jim Simons’ Renaissance Technologies. Even after his passing in 2024, billionaire investor and […]

Insider Monkey 3 days ago

VRTX
My Favorite Tariff Safe-Haven Stock to Buy on the Dip

Recently, investors have worried about the impact of the U.S.’s import tariffs on corporate earnings. Certain companies that don’t heavily depend on imports from countries such as China may not suffer from President Trump’s tariff plan. What's driven this negative momentum is investors' concerns about the potential impact of import tariffs on corporate earnings.

Motley Fool 4 days ago

VRTX

^GSPC
Vertex Pharmaceuticals Incorporated (VRTX) Surged On a Recovery in Investor Sentiment

Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund returned 2.54% (Institutional Shares) in the quarter compared to a 3.87% gain for the Russell 3000 Health Care Index (benchmark) and a 4.72% decline for the Russell […]

Insider Monkey 5 days ago

VRTX
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Vertex (VRTX). This makes it worthwhile to examine what the stock has in store.

Zacks 5 days ago

VRTX
Vertex Pharmaceuticals Incorporated Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

It's shaping up to be a tough period for Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ), which a week ago released...

Simply Wall St. 5 days ago

VRTX
4 No-Brainer Stocks to Buy Right Now

The current volatile situation shouldn't preclude investors from buying stocks. Eli Lilly, Vertex, Meta Platforms, and Netflix all stand to enjoy solid growth. Market volatility and near-term uncertainty can be challenging to deal with these days -- or at any time.

Motley Fool 5 days ago

META

LLY

NFLX
Unpacking Q1 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q1, starting with Vertex Pharmaceuticals (NASDAQ:VRTX).

StockStory 5 days ago

VRTX

UTHR

ABBV
Stocks to Watch Recap: Palantir, Ford, Mattel, DoorDash

🔎 After-Market Activity: Super Micro Computer (SMCI) stock and Rivian Automotive (RIVN) shares fell after the companies released postmarket earnings, while Advanced Micro Devices (AMD) rose following its report.

The Wall Street Journal 8 days ago

VRTX

KLG

DASH
Vertex Pharmaceuticals Topples 10% On A Series Of First-Quarter Setbacks

Vertex stock skidded Tuesday on a series of first-quarter setbacks that included light sales, slow uptake for two drugs and a paused study.

Investor's Business Daily 8 days ago

VRTX
Stock Market Today: Dow Jones, S&P 500 Fall Again; Gold Stocks Rally While Palantir Tumbles (Live Coverage)

The major indexes held on to large losses in the final hour of trading Tuesday. But gold stocks rallied.

Investor's Business Daily 8 days ago

HIMS

VRTX

PLTR
Uber-Pony AI partnership, EVgo boost, Vertex earnings miss

Yahoo Finance host Josh Lipton tracks today's top moving stocks and biggest market stories in this Market Minute, including Uber's (UBER) partnership with Chinese robotaxi company Pony AI (PONY) in the Middle East, EVgo's (EVGO) stock boost from earnings, and Vertex Pharmaceuticals (VRTX) shares taking a hit after missing earnings estimates. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.

Yahoo Finance Video 8 days ago

UBER

VRTX

EVGO
Vertex Pharmaceuticals (NasdaqGS:VRTX) Raises Guidance Despite Intangible Asset Impairment Charge

Vertex Pharmaceuticals (NasdaqGS:VRTX) recently reported a decline in net income and EPS for Q1 2025, despite a rise in revenue, which was accompanied by a large $379 million impairment charge related to its diabetes treatment program. Additionally, the company increased its full-year revenue guidance. Over the past month, Vertex's stock price moved up 5%, aligning it with broader market trends. The market's recovery, despite recent fluctuations and investors' awaiting clarity on tariffs and...

Simply Wall St. 8 days ago

VRTX
Vertex Reports First Quarter 2025 Financial Results

BOSTON, May 05, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the first quarter ended March 31, 2025, and raised the low end of its total revenue guidance range by $100 million, from $11.75 billion to $12 billion to a new range of $11.85 billion to $12 billion.

Business Wire 9 days ago

VRTX
5 Growth Stocks to Buy in May and Go Away

The Trade Desk's share price has been clobbered this year, but its prospects are bright. Vertex Pharmaceuticals' impressive momentum should continue with new drugs on the market and a promising pipeline. The premise is that stock market returns are often lower between May and October than from November to April.

Motley Fool 10 days ago

NVDA

AMZN

META

Performance Overview

Return	VRTX.MX	S&P 500 (^GSPC)
YTD	-1.61%	+0.19%
1-Year	+17.09%	+12.31%
3-Year	+65.44%	+46.44%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Vertex Pharmaceuticals Incorporated (VRTX.MX)

Are Investors Making a Big Mistake Dumping Shares of CRISPR Therapeutics?

Q1 Therapeutics Earnings: United Therapeutics (NASDAQ:UTHR) Impresses

2 Biotech Stocks That Are Screaming Buys in May

This Stock Just Dropped by 12% in 1 Day. History Says This Will Happen Next

Prediction: These 2 Stocks Will Outperform the Market in the Next Five Years

Can Buying CRISPR Therapeutics and Holding It Forever Make You a Millionaire?

Is Vertex Pharmaceuticals (VRTX) Among the Best Stocks to Buy According to Jim Simons’ Renaissance Technologies?

My Favorite Tariff Safe-Haven Stock to Buy on the Dip

Vertex Pharmaceuticals Incorporated (VRTX) Surged On a Recovery in Investor Sentiment

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Vertex Pharmaceuticals Incorporated Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

4 No-Brainer Stocks to Buy Right Now

Unpacking Q1 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks

Stocks to Watch Recap: Palantir, Ford, Mattel, DoorDash

Vertex Pharmaceuticals Topples 10% On A Series Of First-Quarter Setbacks

Stock Market Today: Dow Jones, S&P 500 Fall Again; Gold Stocks Rally While Palantir Tumbles (Live Coverage)

Uber-Pony AI partnership, EVgo boost, Vertex earnings miss

Vertex Pharmaceuticals (NasdaqGS:VRTX) Raises Guidance Despite Intangible Asset Impairment Charge

Vertex Reports First Quarter 2025 Financial Results

5 Growth Stocks to Buy in May and Go Away

Performance Overview